Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients
about
Current perspectives on HIV-1 antiretroviral drug resistanceAdded value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjectsHIV-1 Genetic Variability and Clinical ImplicationsAlternative methods to analyse the impact of HIV mutations on virological response to antiviral therapyFactors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patientsScoring methods for building genotypic scores: an application to didanosine resistance in a large derivation setHIV-1 drug resistance in recently HIV-infected pregnant mother's naïve to antiretroviral therapy in Dodoma urban, Tanzania.Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008)Use of different inhibitory quotients to predict early virological response to tipranavir in antiretroviral-experienced human immunodeficiency virus-infected patients.New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir.Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease.Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland.High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectionComparison of drug resistance scores for tipranavir in protease inhibitor-naive patients infected with HIV-1 B and non-B subtypes.2014 Update of the drug resistance mutations in HIV-1Amide hydrogen exchange in HIV-1 subtype B and C proteases--insights into reduced drug susceptibility and dimer stability.Possible paths and potential barriers to successfully modeling drug resistance.Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort
P2860
Q26852626-F02D19B8-9342-4DDB-82BF-6069DF7C4C44Q28478134-92901A82-0B9B-494B-AEAC-FF5058CBCA73Q30352010-F1D20324-BDC1-4E17-AAA1-859D1486BEAEQ33378828-98EB6E6D-46CA-4457-B6B3-81170FD0B70EQ33558937-61D8486D-873B-4D8C-84BA-75E2598DE64AQ34650691-24C85BC2-8220-4AB0-A86A-1D8DFACD79D3Q34993070-F265181C-E57B-4395-9CCA-D7B63F1F119CQ36250342-7ACDFBBD-B1CC-451E-9DD6-53353E2BAB5AQ37268341-763FD08D-A0E8-49A3-B39B-35792B63B768Q37392816-C0502C3B-1183-4813-8AB8-FEF8F14575FDQ37579219-6FCFB877-9DE2-45FD-A590-D414B7AB387BQ37598398-6DF1C6DF-5511-42D0-9634-4C27082FF1E5Q37643256-F0F56C10-FA5A-49CC-8F34-DA8FEBD36A25Q37696892-F0BC95D6-DFB6-4EAE-9609-424D4779D961Q38726300-B5EADC99-7FE3-46DD-8AB7-FBD59EBF78FFQ39498339-DD82914E-2885-4106-B698-A466F734048AQ42184665-8F9AD01D-D6C0-402E-A9F9-64C7ED47CA53Q43833882-6BD02B78-9604-43C2-95DB-D7CA93492D8CQ56449116-6DD94274-0658-48D4-AC21-89E177629BF7
P2860
Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Tipranavir-ritonavir genotypic ...... inhibitor-experienced patients
@en
type
label
Tipranavir-ritonavir genotypic ...... inhibitor-experienced patients
@en
prefLabel
Tipranavir-ritonavir genotypic ...... inhibitor-experienced patients
@en
P2093
P2860
P50
P356
P1476
Tipranavir-ritonavir genotypic ...... inhibitor-experienced patients
@en
P2093
Anne Signori-Schmuck
Annick Ruffault
Bernard Masquelier
Brigitte Montes
Chakib Alloui
Corinne Amiel
Francis Barin
Georges Dos Santos
Magali Bouvier-Alias
Marc Lavignon
P2860
P304
P356
10.1128/AAC.00133-08
P407
P50
P577
2008-07-14T00:00:00Z